April 22, 2024

Webinar: Advancing medicinal chemistry with high-throughput low-volume liquid handling

Webinar: Advancing medicinal chemistry with high-throughput low-volume liquid handling

Developing pharmaceutical compounds with improved efficacy and specificity profiles means manipulating small molecules at the nanoscale. Since a molecule’s structure determines its function, approaches that access diverse molecular structures are crucial.

Advances in computational methods and automation have significantly enhanced medicinal chemists’ ability to explore vast chemical spaces and validate novel compounds at scale. For example, by integrating virtual screening with high-throughput experimentation (HTE), scientists can iteratively prioritize, validate, and optimize promising candidates, shortening discovery and development timelines.

In this webinar, we will explore how automation—particularly low-volume liquid handling—drives throughput in medicinal chemistry by increasing the number of data points generated per nanomolar-scale experiment. We will also discuss how positive displacement technology overcomes challenges in reproducibility by enabling precise handling of difficult-to-manage liquids at ultra-low volumes. Case studies from leading research institutes will highlight how these technologies are successfully advancing scientific progress.

register now

Our latest News

discover more
How the Ebola virus multiplies in cells

How the Ebola virus multiplies in cells

Like all viruses, the Ebola virus is dependent on host cells in order to replicate. Researchers at Heidelberg University Hospital, in collaboration with colleagues from the Friedrich Loeffler Institute, have been able to show for the first time using state-of-the-art imaging techniques how the replication compartments of the Ebola virus change during replication in infected […]

New weapons against viruses

New weapons against viruses

Dr. Petr Chlanda, virologist and research group leader at the Heidelberg Medical Faculty of Heidelberg University, has been awarded more than 720,000 euros in funding from the European Union for his research into new therapies against viruses. His work is part of the interdisciplinary, international DEFENDER project, which is developing innovative approaches to combat emerging […]

BioChatter: making large language models accessible for biomedical research

BioChatter: making large language models accessible for biomedical research

Introducing an open-source large language model (LLM) framework designed for custom biomedical research Summary Large language models (LLMs) have transformed how many of us work, from supporting content creation and coding to improving search engines. However, the lack of transparency, reproducibility, and customisation of LLMs remains a challenge that restricts their widespread use in biomedical […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp